| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(L) | 527 | 58.7% | -0.96 | 270 | 72.6% |
| CA(L) | 100 | 11.1% | -4.06 | 6 | 1.6% |
| CRE(L) | 58 | 6.5% | -0.50 | 41 | 11.0% |
| CentralBrain-unspecified | 63 | 7.0% | -1.81 | 18 | 4.8% |
| b'L(L) | 28 | 3.1% | -0.81 | 16 | 4.3% |
| SLP(L) | 34 | 3.8% | -2.77 | 5 | 1.3% |
| PLP(L) | 30 | 3.3% | -4.91 | 1 | 0.3% |
| SCL(L) | 27 | 3.0% | -3.17 | 3 | 0.8% |
| PED(L) | 14 | 1.6% | -0.81 | 8 | 2.2% |
| LH(L) | 16 | 1.8% | -4.00 | 1 | 0.3% |
| LAL(L) | 0 | 0.0% | inf | 3 | 0.8% |
| bL(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s3 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 73 | DA | 163 | 19.5% | 0.8 |
| KCg-m (L) | 97 | DA | 131 | 15.7% | 0.5 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 67 | 8.0% | 0.0 |
| KCg-s2 (L) | 1 | DA | 62 | 7.4% | 0.0 |
| PAM08 (L) | 12 | DA | 41 | 4.9% | 0.8 |
| APL (L) | 1 | GABA | 40 | 4.8% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 38 | 4.5% | 0.0 |
| PPL103 (R) | 1 | DA | 34 | 4.1% | 0.0 |
| KCg-s4 (L) | 1 | DA | 27 | 3.2% | 0.0 |
| DPM (L) | 1 | DA | 16 | 1.9% | 0.0 |
| LoVP51 (L) | 1 | ACh | 15 | 1.8% | 0.0 |
| KCg (L) | 1 | DA | 15 | 1.8% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 15 | 1.8% | 0.0 |
| PAM08 (R) | 8 | DA | 14 | 1.7% | 0.7 |
| KCg-s1 (L) | 1 | DA | 12 | 1.4% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 12 | 1.4% | 0.0 |
| PPL103 (L) | 1 | DA | 11 | 1.3% | 0.0 |
| PAM07 (L) | 6 | DA | 11 | 1.3% | 0.7 |
| VP1m_l2PN (L) | 1 | ACh | 10 | 1.2% | 0.0 |
| SLP360_a (L) | 1 | ACh | 6 | 0.7% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 6 | 0.7% | 0.0 |
| PAM12 (L) | 4 | DA | 6 | 0.7% | 0.6 |
| PAM01 (L) | 6 | DA | 6 | 0.7% | 0.0 |
| PAM05 (L) | 3 | DA | 5 | 0.6% | 0.6 |
| PAM05 (R) | 2 | DA | 5 | 0.6% | 0.2 |
| PAM02 (L) | 2 | DA | 5 | 0.6% | 0.2 |
| M_lPNm13 (L) | 2 | ACh | 5 | 0.6% | 0.2 |
| PAM12 (R) | 4 | DA | 4 | 0.5% | 0.0 |
| KCa'b'-ap1 (L) | 4 | DA | 4 | 0.5% | 0.0 |
| LHPV9b1 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| SLP360_d (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| MBON09 (L) | 2 | GABA | 3 | 0.4% | 0.3 |
| SMP146 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| LoVP38 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| PPL101 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| PPL101 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| KCab-p (L) | 2 | DA | 2 | 0.2% | 0.0 |
| SLP438 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CB0951 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE022 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP080 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| KCab-s (L) | 1 | DA | 1 | 0.1% | 0.0 |
| LHPV6k1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PAM07 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| PLP171 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPV7c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP67 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP70 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PPL102 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON21 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL357 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MBON11 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON05 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| DNp30 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg-s3 | % Out | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 73 | DA | 170 | 16.3% | 0.7 |
| KCg-m (L) | 115 | DA | 152 | 14.6% | 0.5 |
| PAM08 (L) | 16 | DA | 60 | 5.7% | 1.2 |
| MBON05 (R) | 1 | Glu | 54 | 5.2% | 0.0 |
| KCg-s2 (L) | 1 | DA | 52 | 5.0% | 0.0 |
| MBON09 (L) | 2 | GABA | 51 | 4.9% | 0.0 |
| APL (L) | 1 | GABA | 35 | 3.4% | 0.0 |
| DPM (L) | 1 | DA | 27 | 2.6% | 0.0 |
| MBON26 (L) | 1 | ACh | 26 | 2.5% | 0.0 |
| KCg-s4 (L) | 1 | DA | 23 | 2.2% | 0.0 |
| PAM07 (L) | 7 | DA | 23 | 2.2% | 0.4 |
| MBON33 (L) | 1 | ACh | 21 | 2.0% | 0.0 |
| KCg (L) | 1 | DA | 19 | 1.8% | 0.0 |
| MBON11 (L) | 1 | GABA | 19 | 1.8% | 0.0 |
| MBON04 (R) | 1 | Glu | 15 | 1.4% | 0.0 |
| PPL103 (R) | 1 | DA | 15 | 1.4% | 0.0 |
| MBON32 (L) | 1 | GABA | 14 | 1.3% | 0.0 |
| MBON35 (L) | 1 | ACh | 14 | 1.3% | 0.0 |
| MBON01 (L) | 1 | Glu | 12 | 1.1% | 0.0 |
| KCg-s1 (L) | 1 | DA | 12 | 1.1% | 0.0 |
| PAM08 (R) | 6 | DA | 12 | 1.1% | 0.4 |
| PAM12 (L) | 4 | DA | 11 | 1.1% | 0.6 |
| KCab-p (L) | 8 | DA | 11 | 1.1% | 0.4 |
| CRE048 (L) | 1 | Glu | 10 | 1.0% | 0.0 |
| LAL159 (L) | 1 | ACh | 10 | 1.0% | 0.0 |
| PAM01 (L) | 5 | DA | 10 | 1.0% | 0.3 |
| MBON27 (L) | 1 | ACh | 8 | 0.8% | 0.0 |
| PPL101 (L) | 1 | DA | 8 | 0.8% | 0.0 |
| MBON21 (L) | 1 | ACh | 8 | 0.8% | 0.0 |
| CRE080_c (L) | 1 | ACh | 7 | 0.7% | 0.0 |
| MBON29 (L) | 1 | ACh | 7 | 0.7% | 0.0 |
| PPL103 (L) | 1 | DA | 7 | 0.7% | 0.0 |
| MBON22 (L) | 1 | ACh | 6 | 0.6% | 0.0 |
| PPL202 (L) | 1 | DA | 5 | 0.5% | 0.0 |
| PAM12 (R) | 3 | DA | 5 | 0.5% | 0.6 |
| SMP376 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| CRE080_d (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| PAM01 (R) | 2 | DA | 4 | 0.4% | 0.0 |
| FB4K (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| MBON05 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| CRE100 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| FB4Y (L) | 2 | 5-HT | 3 | 0.3% | 0.3 |
| PAM05 (L) | 2 | DA | 3 | 0.3% | 0.3 |
| PAM05 (R) | 2 | DA | 3 | 0.3% | 0.3 |
| PAM02 (L) | 2 | DA | 3 | 0.3% | 0.3 |
| PAM07 (R) | 2 | DA | 3 | 0.3% | 0.3 |
| KCa'b'-ap1 (L) | 3 | DA | 3 | 0.3% | 0.0 |
| SMP049 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| PPL104 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| SMP114 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| PAM02 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| PAM15 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| CRE080_a (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| FB4K (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LAL002 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| aMe26 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL102 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| PPL101 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| CRE021 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LoVC20 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 2 | 0.2% | 0.0 |
| FB4R (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| SLP461 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE040 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON03 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV9b1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE069 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE049 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP075 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE049 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE070 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1699 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| ATL035 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| ATL039 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE067 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE062 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP360_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE044 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE066 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE027 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP473 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LAL101 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| FB5I (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV3f1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVP45 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON20 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE023 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
